Andrew James Belfield

Person

  • Abingdon, GB

Patents Grantslast 30 patents

  • Information Patent Grant

    Hydroxamates as inhibitors of histone deacetylase

    • Patent number 8,962,825
    • Issue date Feb 24, 2015
    • GlaxoSmithKline Intellectual Property Development Limited
    • David Charles Festus Moffat
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Histone deacetylase inhibitors

    • Patent number 7,932,246
    • Issue date Apr 26, 2011
    • Chroma Therapeutics Ltd.
    • David Festus Charles Moffat
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    ENZYME INHIBITORS

    • Publication number 20140155439
    • Publication date Jun 5, 2014
    • CHROMA THERAPEUTICS LTD.
    • Alastair David Graham Donald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENZYME INHIBITORS

    • Publication number 20130303576
    • Publication date Nov 14, 2013
    • Alastair David Graham Donald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENZYME INHIBITORS

    • Publication number 20120149736
    • Publication date Jun 14, 2012
    • CHROMA THERAPEUTICS LTD.
    • Alastair David Graham Donald
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE

    • Publication number 20100317678
    • Publication date Dec 16, 2010
    • CHROMA THERAPEUTICS LTD.
    • David Festus Charles Moffat
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Histone Deacetylase Inhibitors

    • Publication number 20100152155
    • Publication date Jun 17, 2010
    • CHROMA THERAPEUTICS LTD.
    • David Festus Charles Moffat
    • C07 - ORGANIC CHEMISTRY